Because of the importance of SIRT1 in AD pathogenesis and its decrease with age, in the future, pharmacotherapy directed toward histone modifications could be employed to target the network of genes regulated by SIRT1 reduction 218, 277, 664. The gene discussed is SIRT1; the disease is Alzheimer disease.